Revolutionizing treatment for patients in need

Scroll To Discover
Young woman smiling. Young woman smiling. Young woman smiling.


We’re committed to delivering boundless therapeutic ingenuity

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork. We aim to bring novel therapeutics to patients across a range of conditions with limited treatment options.


Novel therapies, beginning with the eye

For the millions of patients living with Demodex blepharitis, an FDA-approved treatment is on the horizon.

News & Media

Here is the latest from Tarsus

01/04/2022 Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
11/23/2021 Tarsus to Participate at Upcoming Virtual Investor Conferences
11/10/2021 Tarsus to Participate in the Virtual Jefferies London Healthcare Conference 2021
Contact Tarsus

Please reach out to us using the form below.

General Information
Investor Relations
Opt in to be the first to receive the latest Tarsus news
Contact Tarsus

Thank you for getting in touch! Someone from our team will respond shortly.